Abstract:Background: Autophagy, one of protein degradation system, contributes to maintain cellular homeostasis.Dysfunction of autophagy is associated with the development and progression of various liver diseases including nonalcoholic fatty liver disease (NAFLD) and hepatic cancer.Nuclear matrix protein (NMP) has been demonstrated to participate in many cellular functions.Changes in nuclear matrix structures result in alteration of DNA topology and the interaction of various genes with the matrix.The search for specific NMP modifications in tumors is available for diagnostic or prognostic markers for cancer.Here, we performed proteomic analysis of NMP to identify the novel autophagy-related diagnostic biomarker for NAFLD.Method: Insoluble nuclear protein fraction was extracted from the liver of Atg7 F/ F (wild type), Atg7 F/F :alb-Cre (Atg7 KO), C57BL/6J (control) and KKA y mice (NAFLD model).Proteins were separated with two-dimensional electrophoresis and visualized by silver stain.Protein spots were identified by mass spectrometry.Localization of identified proteins in a cell was verified by immunofluorescence using laser-scanning confocal microscope.Western blot analysis was performed to detect NMPs in serum.Localization of importin a4 and b1 in hepatocytes transfected with GFP-importin a4 or b1 plasmid was evaluated by laserscanning confocal microscope.Result: Twelve nuclear insoluble proteins up-regulated in both autophagy-deficient and NAFLD mice liver were identified.14-3-3 z, importin a4 and b1 were expressed in NMP and localized to nucleus in hepatocytes from both Atg7 KO and KKA y mice, in wild type and control mice, these NMPs were distributed into cytoplasm.14-3-3z, importin a4 and b1 were detectable in serum, and expressed in serum from autophagy-deficient mice and NAFLD model higher than wild type and control mice.Treatment with mTOR inhibitor rapamycin down-regulated the accumulation of 14-3-3 z in NMPs from KKA y mice.Importin a4 and b1 was translocated into nucleus by incubation with tunicamycin or H 2 O 2 for 12 hours.Conclusion: These results suggest that loss of autophagy alters expression of several nuclear proteins.Three autophagy-related NMP 14-3-3z, importin a4 and b1 were up-regulated in NAFLD model and detected in serum.Accumulation of 14-3-3z in NMPs is suggested to be associated with activation of mTOR.Increases in importin a4 and b1 in these NMPs indicate ER stress and oxidative stress.Evaluation of serum level of these NMPs may be useful tool for diagnosis of NAFLD with autophagy dysfunction.

Proteomic Analysis of Liver Mitochondria from Rats with Nonalcoholic Steatohepatitis

Protein Profiling and Functional Analysis of Liver Mitochondria from Rats with Nonalcoholic Steatohepatitis

Functional Proteomic Analysis of Nonalcoholic Fatty Liver Disease in Rat Models: Enoyl-coenzyme a Hydratase Down-Regulation Exacerbates Hepatic Steatosis

Sa1668 Proteomic Analysis of Nonalcoholic Fatty Liver Disease: Attenuation of Coactosin-like Protein-1 Protects Liver from Steatosis and Injury

Differentially expressed proteins obtained by label-free quantitative proteomic analysis reveal affected biological processes and functions in Western diet-induced steatohepatitis

Integration of Metabolomics, Lipidomics, and Proteomics Reveals the Metabolic Characterization of Nonalcoholic Steatohepatitis.

Oxidative Stress Linked Organ Lipid Hydroperoxidation and Dysregulation in Mouse Model of Nonalcoholic Steatohepatitis: Revealed by Lipidomic Profiling of Liver and Kidney

Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis

Recent Progress of Proteomics in Nonalcoholic Fatty Liver Disease*

Hepatocyte Mitochondrial Injury and the Change of Adenosine Triphosphate Storage in Rat Nonalcoholic Steatohepatitis

Sa1667 Hepatic-Specific Activation of Peroxisome Proliferator-Activated Receptor Y Coactivator-1α Protected Against Steatohepatitis

Effect of Mir-146 Targeted Hdmcp Up Regulation in the Pathogenesis of Nonalcoholic Steatohepatitis

Lipidomics Workflow for Analyzing Lipid Profiles Using Multiple Reaction Monitoring (MRM) in Liver Homogenate of Mice with Non-alcoholic Steatohepatitis (NASH)

Integrated Multichip Analysis Identifies Potential Key Genes in the Pathogenesis of Nonalcoholic Steatohepatitis

A Model of Non-alcoholic Steatohepatitis on Rats

The metabolomics analysis of liver and serum in different phenotypes of non-alcoholic fatty liver disease

Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice

Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis

Integrating Multi-Omics Reveals Crucial Biomarkers in Non-Alcoholic Fatty Liver Disease

Impaired Mitophagy Triggers NLRP3 Inflammasome Activation During the Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis

Single and Mixed Strains of Probiotics Reduced Hepatic Fat Accumulation and Inflammation and Altered Gut Microbiome in a Nonalcoholic Steatohepatitis Rat Model